What is it about?
The Fund Yvonne and Jacques François-de Meurs supports scientific research on biochemical action mechanisms in cancer.
Young post-doctoral researchers can apply for fundamental, pre-clinical or translational research projects.
The Fund Yvonne and Jacques François-de Meurs is launching a joint call with other Funds. The next call will be launched in 2025
The Fund Yvonne and Jacques François-de Meurs was created to help medical scientific research in Belgium in the field of diabetes and cancer. In particular, it supports research projects that bring creativity and innovation and have perspectives of concrete application. In the period 2012 - 2018, diabetes was privileged. From 2019 onwards, the focus lies on cancer.
Soutenus en 2023, pour une période de deux ans :
- Université libre de Bruxelles (Evelyne Collignon) - An innovative epitranscriptomic approach to target cancer persister cells
- KU Leuven (Marlies Vanden Bempt) - Characterization of non-canonical EZH2 transcriptional complexes to identify new therapeutic targets in peripheral T cell lymphoma
Le Fonds lance un appel conjoint avec d’autres Fonds en 2025.